Gilead Sciences
GILD
GILD
2,009 hedge funds and large institutions have $119B invested in Gilead Sciences in 2025 Q1 according to their latest regulatory filings, with 277 funds opening new positions, 690 increasing their positions, 826 reducing their positions, and 112 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more call options, than puts
Call options by funds: $1.2B | Put options by funds: $1.19B
0.19% more ownership
Funds ownership: 85.31% → 85.5% (+0.19%)
16% less repeat investments, than reductions
Existing positions increased: 690 | Existing positions reduced: 826
Holders
2,009
Holding in Top 10
51
Calls
$1.2B
Puts
$1.19B
Top Buyers
| 1 | +$1.88B | |
| 2 | +$1.15B | |
| 3 | +$564M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$243M |
| 5 |
Holocene Advisors
New York
|
+$238M |
Top Sellers
| 1 | -$1.87B | |
| 2 | -$856M | |
| 3 | -$439M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$370M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$344M |